carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine
Term · Oncology and biomedicine · MLC-T-ONC-012304
A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells.
| Identifier | MLC-T-ONC-012304 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CEA(6D) VRP vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012304",
"term": "carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells.",
"abbreviation": "CEA(6D) VRP vaccine",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carcinoembryonic-antigen-peptide-1-6d-virus-like-replicon-particles-vaccine/"
}
Record 4,220 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.